BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Rosiglitazone
,
rs3825942
,
EGFR
,
cell-cell adhesion
,
Lung cancer
,
Lung
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
prodrug
Summary
General Info
Curated Studies
Most Correlated Studies
B-lymphoma U937 cells treated with nitric oxide releasing prodrug JS-K (timecourse)
HCT116 cells treated with Decitabine, Azacytidine and Decitabine pro-drugs
Pancreatic cancer L3.6pl cells with gemcitabine resistance
Pancreatic carcinoma S2013 and MIA PaCa-2 cells and xenografts treated with triptolide or minnelide
Breast cancer MCF7 cells treated with sphingosine-1-phosphate, FTY720 or SAHA
Explore Curated Studies Results
Literature
Most Relevant Literature
Bioorthogonal chemistry for prodrug activation in vivo.
Unveiling the mechanism of activation of the Te(IV) prodrug AS101. New chemical insights towards a b…
Tetrasulfide bond boosts the anti-tumor efficacy of dimeric prodrug nanoassemblies.
The landscape of small-molecule prodrugs.
An Enzymatic Prodrug-like Route to Thio and Selenoamides.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy Study of Aminoflavone Prodrug to Treat Breast Cancer
Bioavailability Study of Prodrug of GLPG0187 in Healthy Volunteers
The Safety and Effectiveness of PMPA Prodrug in HIV-Infected Patients
Genetic Determinants of ACEI Prodrug Activation
CAN-2409 Plus Prodrug With Standard of Care Immune Checkpoint Inhibitor for Stage III/IV NSCLC
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ